Daniel Kejzman

901 total citations
2 papers, 3 citations indexed

About

Daniel Kejzman is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology. According to data from OpenAlex, Daniel Kejzman has authored 2 papers receiving a total of 3 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Cancer Research and 1 paper in Epidemiology. Recurrent topics in Daniel Kejzman's work include Cancer Genomics and Diagnostics (2 papers), Renal cell carcinoma treatment (2 papers) and Multiple and Secondary Primary Cancers (1 paper). Daniel Kejzman is often cited by papers focused on Cancer Genomics and Diagnostics (2 papers), Renal cell carcinoma treatment (2 papers) and Multiple and Secondary Primary Cancers (1 paper). Daniel Kejzman collaborates with scholars based in Israel, United States and South Korea. Daniel Kejzman's co-authors include Mario A. Eisenberger, Avishay Sella, Michael A. Carducci, Avivit Peer, Avivit Neumann, Eliahu Gez, Victoria Neiman, Keren Rouvinov, David Sarid and Svetlana Kovel and has published in prestigious journals such as Journal of Clinical Oncology.

In The Last Decade

Daniel Kejzman

2 papers receiving 3 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Kejzman Israel 2 3 3 1 1 2 3
Hilda Solano-Lira Switzerland 2 3 1.0× 2 0.7× 1 1.0× 2 6
Bernardo Neves Portugal 3 4 1.3× 4 1.3× 7 10
Suzanne L. Meinig United States 2 3 1.0× 4 1.3× 2 6
José Carlos Villa-Guzmán Spain 2 2 0.7× 2 0.7× 1 1.0× 1 1.0× 3 5
Hannes Jürgens Estonia 2 3 1.0× 3 1.0× 1 1.0× 2 2.0× 2 3
Danya Cheeseman United Kingdom 2 5 1.7× 3 1.0× 1 1.0× 1 1.0× 2 7
Michael R.G. Dack United Kingdom 2 2 0.7× 2 0.7× 2 7
Érica Mendonça Portugal 1 5 1.7× 4 1.3× 2 6
N. Tao China 2 2 0.7× 2 0.7× 1 1.0× 1 1.0× 2 5
Xiyan Lian China 2 2 0.7× 2 0.7× 3 5

Countries citing papers authored by Daniel Kejzman

Since Specialization
Citations

This map shows the geographic impact of Daniel Kejzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Kejzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Kejzman more than expected).

Fields of papers citing papers by Daniel Kejzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Kejzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Kejzman. The network helps show where Daniel Kejzman may publish in the future.

Co-authorship network of co-authors of Daniel Kejzman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Kejzman. A scholar is included among the top collaborators of Daniel Kejzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Kejzman. Daniel Kejzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
1.
Neiman, Victoria, Maya Gottfried, Hans J. Hammers, et al.. (2014). Clinicopathologic factors associated with the development of sunitinib induced hypertension (HTN) in patients (pts) with metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 32(4_suppl). 508–508. 1 indexed citations
2.
Kejzman, Daniel, Maya Gottfried, Hans J. Hammers, et al.. (2014). Patients with metastatic papillary renal cell carcinoma (RCC) who may benefit from sunitinib therapy (tx): Results from an international metastatic RCC database.. Journal of Clinical Oncology. 32(4_suppl). 486–486. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026